Lanolin [8006-54-0]
Referentie HY-N7074-500mg
Formaat : 500mg
Merk : MedChemExpress
| Description | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| In Vitro |
Lanolin, when mixed with olive oil to make an ointment, shows significant protective effects against dermatitis and cancer caused by mineral oil. Its protective effects against tar, however, vary with dosage: it is effective at low doses but may promote cancer at high doses[2]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
| In Vivo |
Lanolin (applied to tails; once daily; 6 days) can improve ringtail symptoms in transgenic rat pups[3]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
|
||||||||||||
| Essai clinique |
|
||||||||||||
| Masse moléculaire |
1293.34 |
||||||||||||
| Formule |
C54H84N16O21 |
||||||||||||
| CAS No. | |||||||||||||
| Appearance |
Oil |
||||||||||||
| Color |
Light yellow to yellow |
||||||||||||
| SMILES |
[Lanolin] |
||||||||||||
| Structure Classification | |||||||||||||
| Initial Source |
sheep's wool |
||||||||||||
| Livraison | Room temperature in continental US; may vary elsewhere. |
||||||||||||
| Stockage |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
||||||||||||
| Solvant et solubilité |
In Vitro:
DMSO : 10 mg/mL (7.73 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) Preparing
Stock Solutions
View the Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles. Select the appropriate dissolution method based on your experimental animal and administration route.
For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
|
||||||||||||
| Pureté et documentation | |||||||||||||
| Références |
|

